Wernicke—Korsakoff Syndrome

  • David A. Greenberg
  • Ivan Diamond

Abstract

Several specific disorders of the nervous system develop in patients with chronic alcoholism. However, alcoholics are often subject to malnutrition, head trauma, seizures, and a variety of systemic disorders, and it is often difficult to determine the relative contribution of direct and indirect effects of alcohol in the pathogenesis of the alcohol-related neurologic disorders. About a century has passed since Wernicke and Korsakoff separately described components of the syndrome that now bears their names. During that time, we have learned a great deal about the relationship between alcoholism and the Wernicke—Korsakoff syndrome, and effective treatment for the acute phase of the disorder has been developed. Despite these accomplishments, the specific biochemical derangement that produces structural pathology and clinical symptoms characteristic of the Wernicke—Korsakoff syndrome has not been identified.

Keywords

Thiamine Deficiency Transient Global Amnesia Maple Syrup Urine Disease Korsakoff Syndrome Local Cerebral Glucose Utilization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wagener HP, Weir J: Ocular lesions associated with postoperative and gestational nutritional deficiency. Am J Ophthalmol 20: 253–259, 1937Google Scholar
  2. 2.
    Ecker AD, Woltman HW: Is nutritional deficiency the basis of Wemicke’s disease? Report of a case. JAMA 112: 1794–1796, 1939CrossRefGoogle Scholar
  3. 3.
    Richmond J: Wemicke’s encephalopathy associated with digitalis poisoning. Lancet 1: 344–345, 1959PubMedCrossRefGoogle Scholar
  4. 4.
    Drenick EJ, Joven CB, Swendseid ME: Occurrence of acute Wemicke’s encephalopathy during prolonged starvation for the treatment of obesity. N Engl J Med 274: 937–939, 1966PubMedCrossRefGoogle Scholar
  5. 5.
    DeReuck JL, Sieben GJ, Sieben-Praet MR, et al: Wernicke’s encephalopathy in patients with tumors of the lymphoid—hemopoietic systems. Arch Neurol 37: 338–341, 1980CrossRefGoogle Scholar
  6. 6.
    Rimalovski AB, Aronson SM: Pathogenetic observation in Wernicke—Korsakoff encephalopathy. Trans Am Neurol Assoc 91: 29–31, 1966Google Scholar
  7. 7.
    Fans AA: Wernicke’s encephalopathy in uremia. Neurology 22: 1293–1297, 1972CrossRefGoogle Scholar
  8. 8.
    Nadel AM, Burger PC: Wernicke encephalopathy following prolonged intravenous therapy. JAMA 235: 2403–2405, 1976PubMedCrossRefGoogle Scholar
  9. 9.
    Kramer J, Goodman JA: Wernicke’s encephalopathy. Complication of intravenous hyperalimentation. JAMA 238: 2176–2177, 1977PubMedCrossRefGoogle Scholar
  10. 10.
    Lopez RI, Collins GH: Wernicke’s encephalopathy. A complication of chronic hemodialysis. Arch Neurol 18: 248–259, 1968PubMedCrossRefGoogle Scholar
  11. 11.
    Victor M, Adams RD, Collins GH: The Wernicke—Korsakoff Syndrome. A Clinical and Pathological Study of 245 Patients, 82 with Post-Mortem Examinations (Contemporary Neurology Series, Vol 7 ). Philadelphia, FA Davis, 1971Google Scholar
  12. 12.
    Wallis WE, Willoughby E, Baker P: Coma in the Wemicke—Korsakoff syndrome. Lancet 2: 400–401, 1978PubMedCrossRefGoogle Scholar
  13. 13.
    Lipton JM, Payne H, Garza HR, et al: Thermolability in Wemicke’s encephalopathy. Arch Neurol 35: 750–753, 1978PubMedCrossRefGoogle Scholar
  14. 14.
    Ghez C: Vestibular paresis: A clinical feature of Wernicke’s disease. J Neurol Neurosurg Psychiatry 32: 134–139, 1969PubMedCrossRefGoogle Scholar
  15. 15.
    Novak DJ, Victor M: Affection of the vagus and sympathetic nerves in alcoholic polyneuropathy. Arch Neurol 30: 273–284, 1974PubMedCrossRefGoogle Scholar
  16. 16.
    Malamud N, Skillikorn SA: Relationship between the Wernicke and the Korsakoff syndrome. Arch Neurol Psychiatry 76: 586–596, 1956CrossRefGoogle Scholar
  17. 17.
    Thomson AD, Baker H, Leevy CM: Patterns of 35S-thiamine hydrochloride absorption in the malnourished alcoholic patient. J Lab Clin Med 76: 34–45, 1970PubMedGoogle Scholar
  18. 18.
    Victor M, Adams RD, Mancall EL: A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1: 579–688, 1959CrossRefGoogle Scholar
  19. 19.
    Fisher CM, Adams RD: Transient global amnesia syndrome. Acta Neurol Scand 40 (Suppl 9): 7–82, 1964Google Scholar
  20. 20.
    Caronna JJ, Finklestein S: Neurological syndromes after cardiac arrest. Stroke 9: 517–520, 1978PubMedCrossRefGoogle Scholar
  21. 21.
    Smith JS, Brandon S: Morbidity from acute carbon monoxide poisoning at three-year follow-up. Br Med J 1: 318–321, 1973PubMedCrossRefGoogle Scholar
  22. 22.
    Benson FD, Marsden CD, Meadows JC: The amnesic syndrome of posterior cerebral artery occlusion. Acta Neurol Scand 50: 133–145, 1974PubMedCrossRefGoogle Scholar
  23. 23.
    Friedman HM, Allen N: Chronic effects of complete limbic lobe destruction in man. Neurology 19: 679–690, 1969PubMedCrossRefGoogle Scholar
  24. 24.
    Sprofkin BE, Sciarra D: Korsakoff’s psychosis associated with cerebral tumors. Neurology 2: 427–434, 1952PubMedCrossRefGoogle Scholar
  25. 25.
    Corsellis JAN, Goldberg GJ, Norton AR: “Limbic encephalitis” and its association with carcinoma. Brain 91: 481–496, 1968PubMedCrossRefGoogle Scholar
  26. 26.
    Squire LR, Davis HP: The pharmacology of memory: A Neurobiological perspective. Annu Rev Pharmacol Toxicol 21: 323–356, 1981PubMedCrossRefGoogle Scholar
  27. 27.
    McEntee WJ, Mair RG: Memory impairment in Korsakoff’s psychosis: A correlation with brain noradrenergic activity. Science 202: 905–907, 1978PubMedCrossRefGoogle Scholar
  28. 28.
    McEntee WJ, Mair RG: Memory enhancement in Korsakoff’s psychosis by clonidine: Further evidence for a noradrenergic deficit. Ann Neurol 7: 466–470, 1980PubMedCrossRefGoogle Scholar
  29. 29.
    Oliveros JC, Jandali MK, Timsit-Berthier M, et al: Vasopressin in amnesia. Lancet 1: 42, 1978PubMedCrossRefGoogle Scholar
  30. 30.
    Blake DR, Dodd MJ, Evans JG: Vasopressin in amnesia. Lancet 1: 608, 1978PubMedCrossRefGoogle Scholar
  31. 31.
    LeBoeuf A, Lodge J, Eames PG: Vasopressin and memory in Korsakoff syndrome. Lancet 2: 1370, 1978PubMedCrossRefGoogle Scholar
  32. 32.
    Gubler CJ, Fujiwara M, Dreyfus PM (eds): Thiamine. New York, Wiley, 1976Google Scholar
  33. 33.
    Cooper JR, Pincus JH: The role of thiamine in nervous tissue. Neurochem Res 4: 223–239, 1979PubMedCrossRefGoogle Scholar
  34. 34.
    Blass JP: Thiamin and the Wemicke—Korsakoff syndrome, in Briggs MH (ed): Vitamins in Human Biology and Medicine. Boca Raton, Florida, CRC Press, 1981, pp 107–135Google Scholar
  35. 35.
    Sable HZ, Gubler CJ (eds): Thiamin: Twenty years of progress. Ann NY Acad Sci 378, 1982Google Scholar
  36. 36.
    Hoyumpa AM Jr: Characterization of normal intestinal thiamin transport in animals and man. Ann NY Acad Sci 378: 337–343, 1982PubMedCrossRefGoogle Scholar
  37. 37.
    Spector R: Thiamin homeostasis in the central nervous system. Ann NY Acad Sci 378: 344–354, 1982PubMedCrossRefGoogle Scholar
  38. 38.
    Dreyfus PM: The quantitative histochemical distribution of thiamine in normal rat brain. J Neurochem 4: 183–190, 1959PubMedCrossRefGoogle Scholar
  39. 39.
    Pincus JH, Grove 1: Distribution of thiamine phosphate esters in normal and thiamine-deficient brain. Exp Neurol 28: 477–483, 1970PubMedCrossRefGoogle Scholar
  40. 40.
    Balaghi M, Pearson WN: Tissue and intracellular distribution of radioactive thiamine in normal and thiamine deficient rats. J Nutr 89: 127–142, 1966PubMedGoogle Scholar
  41. 41.
    Elsas LJ II, Danner DJ: The role of thiamin in maple syrup urine disease. Ann NY Acad Sci 378: 404–421, 1982PubMedCrossRefGoogle Scholar
  42. 42.
    Barchi RL: The nonmetabolic role of thiamine in excitable membrane function, in Gubler CJ, Fujiwara M, Dreyfus PM (eds): Thiamine. New York, Wiley, 1976, pp 283–310Google Scholar
  43. 43.
    Eder L, Hirt L, Dunant Y: Possible involvement of thiamine in acetylcholine release. Nature 264: 186–188, 1976PubMedCrossRefGoogle Scholar
  44. 44.
    von Murait A: The role of thiamine in neurophysiology. Ann NY Acad Sci 98: 499–507, 1962Google Scholar
  45. 45.
    Armett CJ, Cooper JR: The role of thiamine in nervous tissue: Effect of antimetabolites of the vitamin on conduction in mammalian nonmyelinated nerve fibers. J Pharmacol Exp Ther 148: 137–143, 1965PubMedGoogle Scholar
  46. 46.
    Eichenbaum JW, Cooper JR: Restoration by thiamine of the action potential in ultraviolet irradiated nerves. Brain Res 32: 258–260, 1971PubMedCrossRefGoogle Scholar
  47. 47.
    von Murait A: Thiamine and peripheral neurophysiology, in Harris RS, Thimann KV (eds): Vitamins and Hormones. New York, Academic Press, 1947, pp 93–116Google Scholar
  48. 48.
    Itokawa Y, Cooper JR: Ion movements and thiamine in nervous tissue. I. Intact nerve preparations. Biochem Pharmacol 19: 985–992, 1970CrossRefGoogle Scholar
  49. 49.
    Cooper JR, Roth RH, Kini MM: Biochemical and physiological function of thiamine in nervous tissue. Nature 199: 609–610, 1963PubMedCrossRefGoogle Scholar
  50. 50.
    Itokawa Y, Schulz RA, Cooper JR: Thiamine in nerve membranes. Biochim Biophys Acta 266: 293–299, 1972PubMedCrossRefGoogle Scholar
  51. 51.
    Berman K, Fishman RA: Thiamine phosphate metabolism and possible coenzyme-independent functions of thiamine in brain. J Neurochem 24: 457–465, 1975PubMedCrossRefGoogle Scholar
  52. 52.
    Dreyfus PM, Victor M: Effects of thiamine deficiency on the central nervous system. Am J Clin Nutr 9: 414–425, 1961PubMedGoogle Scholar
  53. 53.
    Rinehart JF, Friedmann M, Greenberg LD: Effect of experimental thiamine deficiency on the nervous system of the rhesus monkey. Arch Pathol 48: 129–139, 1949Google Scholar
  54. 54.
    Troncoso JC, Johnston MV, Hess KM, et al: Model of Wernicke’s encephalopathy. Arch Neurol 38: 350–354, 1981PubMedCrossRefGoogle Scholar
  55. 55.
    Brody IA, Wilkins RH: Wernicke’s encephalpathy. Arch Neurol 19: 228–232, 1968PubMedCrossRefGoogle Scholar
  56. 56.
    DeWardener HE, Lennox B: Cerebral beriberi (Wernicke’s encephalopathy). Review of 52 cases in a Singapore prisoner-of-war hospital. Lancet 1: 11–17, 1947PubMedCrossRefGoogle Scholar
  57. 57.
    Phillips GB, Victor M, Adams RD, et al: A study of the nutritional defect in Wernicke’s syndrome: The effect of a purified diet, thiamine, and other vitamins on the clinical manifestations. J Clin Invest 31: 859–871, 1952PubMedCrossRefGoogle Scholar
  58. 58.
    Victor M, Adams RD: On the etiology of the alcoholic neurologic diseases with special reference to the role of nutrition. Am J Clin Nutr 9: 379–397, 1961PubMedGoogle Scholar
  59. 59.
    Henderson G, Schenker S: Cerebral metabolic abnormalities in thiamine deficiency, in Rothschild MA, Oratz M, Schreiber SS: Alcohol and Abnormal Protein Biosynthesis. New York, Pergamon Press, 1975, pp 449–456Google Scholar
  60. 60.
    Dreyfus PM: Thiamine-deficiency encephalopathy: Thoughts on its pathogenesis, in Gubler CJ, Fujiwara M, Dreyfus PM (eds): Thiamine. New York, Wiley, 1976, pp 229–243Google Scholar
  61. 61.
    Schenker S, Henderson GI, Hoyumpa AM, et al: Hepatic and Wemicke’s encephalopathies: Current concepts of pathogenesis. Am J Clin Nutr 33: 2719–2726, 1980PubMedGoogle Scholar
  62. 62.
    Thomson AD: Alcohol related structural brain changes. Br Med Bull 38: 87–94, 1982PubMedGoogle Scholar
  63. 63.
    Hakim AM, Pappius HM: The effect of thiamine deficiency on local cerebral glucose utilization. Ann Neurol 9: 334–339, 1981PubMedCrossRefGoogle Scholar
  64. 64.
    Pincus JH, Wells K: Regional distribution of thiamine-dependent enzymes in normal and thiamine-deficient brain. Exp Neurol 37: 495–501, 1972PubMedCrossRefGoogle Scholar
  65. 65.
    McCandless DW, Schenker S: Encephalopathy of thiamine deficiency: Studies of intracerebral mechanisms. J Clin Invest 47: 2268–2280, 1968PubMedCrossRefGoogle Scholar
  66. 66.
    McCandless DW, Cassidy CE: Adenine nucleotides in thiamine deficient rat brain. Res Commun Chem Pathol Pharmacol 14: 579–582, 1976PubMedGoogle Scholar
  67. 67.
    McCandless DW, Curley AD, Cassidy CE: Thiamine deficiency and the pentose phosphate cycle in rats: Intracerebral mechanisms. J Nutr 106: 1144–1151, 1976PubMedGoogle Scholar
  68. 68.
    Smith E: The turnover of myelin in the adult rat. Biochim Biophys Acta 164: 285–293, 1968PubMedCrossRefGoogle Scholar
  69. 69.
    Blass JP, Gibson GE: Abnormality of a thiamine-requiring enzyme in patients with WemickeKorsakoff syndrome. N Engl J Med 297: 1367–1370, 1977PubMedCrossRefGoogle Scholar
  70. 70.
    Itokawa Y, Cooper J: Ion movements and thiamine. II. The release of the vitamin from membrane fragments. Biochim Biophys Acta 196: 274–284, 1970PubMedCrossRefGoogle Scholar
  71. 71.
    Perri V, Sacchi O, Casella C: Nervous transmission in the superior cervical ganglion of the thiamin-deficient rat. Q J Exp Physiol 55: 25–35, 1970PubMedGoogle Scholar
  72. 72.
    Gibson G, Barclay L, Blass J: The role of the cholinergic system in thiamin deficiency. Ann NY Acad Sci 378: 382–403, 1982PubMedCrossRefGoogle Scholar
  73. 73.
    Terry RD, Davies P: Dementia of the Alzheimer’s type. Ann Rev Neurosci 3: 77–95, 1980PubMedCrossRefGoogle Scholar
  74. 74.
    Ito M: Recent advances in cerebellar physiology and pathology, in Kark RAP, Rosenberg RN, Schut LJ (eds): The Inherited Ataxias (Advances in Neurology, Vol 21 ). New York, Raven Press, 1978, pp 59–84Google Scholar
  75. 75.
    Chan-Palay V, Plaitakis A, Nicklas WJ, et al: Autoradiographic demonstration of loss of labeled indoleamine axons in the cerebellum of chronic diet-induced thiamine deficiency. Brain Res 138: 380–384, 1977PubMedCrossRefGoogle Scholar
  76. 76.
    Plaitakis A, Hwang EC, Van Woert MH, et al: Effect of thiamin deficiency on brain neurotramitter systems. Ann NY Acad Sci 378: 367–381, 1982PubMedCrossRefGoogle Scholar
  77. 77.
    Hamel E, Butterworth RF, Barbeau A: Effect of thiamine deficiency on levels of putative amino acid transmitters in affected regions of the rat brain. J Neurochem 33: 575–577, 1979PubMedCrossRefGoogle Scholar
  78. 78.
    Redos JD, Catravas GN, Hunt WA: Ethanol-induced depletion of cerebellar guanosine 3’,5’-cyclic monophosphate. Science 193: 58–59, 1976PubMedCrossRefGoogle Scholar
  79. 79.
    Biggio G, Brodie BB, Costs E, et al: Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex. Proc Natl Acad Sci USA 74: 3592–3596, 1977PubMedCrossRefGoogle Scholar
  80. 80.
    Chan-Palay V, Nilaver G, Palay SL, et al: Chemical heterogeneity in cerebellar Purkinje cells: Existence and coexistence of glutamic acid decarboxylase-like and motilin-like immunoreactivities. Proc Natl Acad Sci USA 78: 7787–7791, 1981PubMedCrossRefGoogle Scholar
  81. 81.
    Chan-Palay V, Lin C-T, Palay S, et al: Taurine in the mammalian cerebellum: Demonstration by autoradiography with [3H1 taurine and immunocytochemistry with antibodies against the taurine-synthesizing enzyme, cysteine-sulfinic acid decarboxylase. Proc Natl Acad Sci USA 79: 2695–2699, 1982PubMedCrossRefGoogle Scholar
  82. 82.
    Chan-Palay V, Palay SL, Wu J-Y: Sagittal cerebellar microbands of taurine neurons: Immunocytochemical demonstration by using antibodies against the taurine-synthesizing enzyme cysteine sulfinic acid decarboxylase. Proc Natl Acad Sci USA 79: 4221–4225, 1982PubMedCrossRefGoogle Scholar
  83. 83.
    Garson JA, Beverley PCL, Coakham HB, et al: Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species. Nature 298: 375–377, 1982PubMedCrossRefGoogle Scholar
  84. 84.
    Caddy KWT, Patterson DL, Biscoe TJ: Use of the UCHTI monoclonal antibody to explore mouse mutants and development. Nature 300: 441–443, 1982PubMedCrossRefGoogle Scholar
  85. 85.
    McDowell JR, LeBlanc HJ: Computed tomographic findings in Wernicke-Korsakoff syndrome. Arch Neurol 41: 453–454, 1984PubMedCrossRefGoogle Scholar
  86. 86.
    Martin PR, Weingartner H, Gordon EK et al: Central nervous system catecholamine metabolism in Korsakoff’s psychosis. Ann Neurol 15: 184–187, 1984PubMedCrossRefGoogle Scholar
  87. 87.
    McEntee WJ, Mair RG, Langlais PJ: Neurochemical pathology in Korsakoff’s psychosis: Implications for other cognitive disorders. Neurology 34: 648–652, 1984PubMedCrossRefGoogle Scholar
  88. 88.
    Martin PR, Higa S, Bums RS et al: Decreased 6-hydroxymelatonin excretion in Korsakoff’s psychosis. Neurology 34: 966–968, 1984PubMedCrossRefGoogle Scholar
  89. 89.
    Sharp FR, Bolger E, Evans K: Thiamine deficiency limits glucose utilization and glial proliferation in brain lesions of symptomatic rats. J Cereb Blood Flow Metabol 2: 203–207, 1982CrossRefGoogle Scholar
  90. 90.
    Sharp FR, Evans K, Bolger E: Local cerebral glucose utilization in the symptomatic thiamine-deficient rat: Increases in fornix and pyramidal tract. Neurology 32: 808–814, 1982PubMedCrossRefGoogle Scholar
  91. 91.
    Hakim AM, Pappius HM: Sequence of metabolic, clinical, and histological events in experimental thiamine deficiency. Ann Neurol 13: 365–375, 1983PubMedCrossRefGoogle Scholar
  92. 92.
    Witt ED, Goldman-Rakic PS: Intermittent thiamine deficiency in the rhesus monkey. I. Progression of neurological signs and neuroanatomical lesions. Ann Neurol 13: 376–395, 1983PubMedCrossRefGoogle Scholar
  93. 93.
    Witt ED, Goldman-Rakic PS: Intermittent thiamine deficiency in the rhesus monkey. II. Evidence for memory loss. Ann Neurol 13: 396–401, 1983PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • David A. Greenberg
    • 1
  • Ivan Diamond
    • 1
  1. 1.Departments of Neurology, Pharmacology, and PediatricsUniversity of California, San Francisco, and Ernest Gallo Clinic and Research Center, San Francisco General HospitalSan FranciscoUSA

Personalised recommendations